Skip to content
Screener

Valhi VHI Chemicals — Deferred Income Tax Expense Benefit

Similar metrics at other companies

Coda Octopus Group, Inc. logo
CODACorporate — Deferred Income Tax Expense Benefit
$3.64K+120%
Paramount Gold Nevada logo
PZGCorporate — Deferred Income Tax Expense Benefit
$0
Lesaka Technologies, Inc. logo
LSAKOther Income Tax — Deferred Income Tax Expense Benefit
-$4.5K-550%
Lesaka Technologies, Inc. logo
LSAKUS — Deferred Income Tax Expense Benefit
-$2.53M
Lesaka Technologies, Inc. logo
LSAKZA — Deferred Income Tax Expense Benefit
-$3.45M-409%
Wave Life Sciences logo
WVESG — Deferred Income Tax Expense Benefit
$0

Other financials

Income statement

See full
Revenue$606.1M+12.2%
Gross profit$120.1M+53.8%
Net income$22.3M+2,378%
EPS (diluted)$0.78+2,500%

Balance sheet

See full
Cash & equivalents$209.7M+11.2%
Total debt$591.4M-7.3%
Total equity$1.0B-2.5%
Total assets$2.6B-6.8%

Cash flow

See full
Operating cash flow$59.1M
CapEx$17.2M+36.5%
Free cash flow-$56.7M+66.4%

Valuation

See full
Market cap$474.06M+7.9%
Enterprise value$855.76M-3.7%
P/S0.2×0.0×

Profitability

See full
Gross margin14.7%-5.3pp
Net margin-2.4%-7.0pp
FCF margin12.9%

Returns & leverage

See full
Return on equity-4.8%-14.5pp
Debt / equity0.6×0.0×
Current ratio3.4×+0.5×

Where this comes from

Reported directly by Valhi in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The source filing: Valhi’s 10-K, filed March 10, 2026.

Filed
Mar 10, 2026, 4:16 PM EDT
Fiscal year
FY2025
Accession
0001104659-26-025847

The 2017 Tax Act limited our business interest expense to the sum of our business interest income and 30% of our adjusted taxable income as defined in the Tax Act. Any business interest expense disallowed as a deduction as a result of the limitation may be carried forward indefinitely. At December 31, 2024 and December 31, 2025, we have recorded deferred tax assets of $23.1 million and $30.6 million, respectively, for the carryforwards associated with the nondeductible portion of our interest expense and have concluded we are required to recognize a valuation allowance for such deferred tax asset under the more-likely-than-not recognition criteria. During 2025 we recognized a non-cash deferred income tax expense of $8.5 million with respect to the valuation allowance recorded on a portion of our additional interest expense carryforwards.

ITEM 15.EXHIBITS

FAQ

What is Valhi's chemicals — deferred income tax expense benefit?
Valhi (VHI) reported chemicals — deferred income tax expense benefit of $2.13M in Q4 2025.
How has Valhi's chemicals — deferred income tax expense benefit changed year-over-year?
Valhi's chemicals — deferred income tax expense benefit increased by 240.0% year-over-year, from $625K to $2.13M.
What is the long-term trend for Valhi's chemicals — deferred income tax expense benefit?
Over 2 years (2023 to 2025), Valhi's chemicals — deferred income tax expense benefit has grown at a 96.6% compound annual growth rate (CAGR), from $2.2M to $8.5M.
What does chemicals — deferred income tax expense benefit mean?
Reflects the net change in deferred tax assets and liabilities arising from temporary differences between the carrying amounts of assets and liabilities for financial reporting and their tax bases within the chemicals segment. This metric highlights the impact of timing differences on future tax obligations or savings. It is essential for understanding the segment's effective tax rate and long-term tax planning strategies.

Ask your AI about Valhi's chemicals — deferred income tax expense benefit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude